Director & Chief Executive Officer
Director & Chief Executive Officer at Apogee Therapeutics, Inc., filing insider transactions between 2026-03-11 and 2026-06-22. Also reports transactions at 1 other company.
| SEC ↗ |
| 2026-06-10 | APGE | Sale | 1,080 | $84.18 | $91K | SEC ↗ |
| 2026-06-10 | APGE | Sale | 1,577 | $85.19 | $134K | SEC ↗ |
| 2026-06-10 | APGE | Sale | 614 | $86.89 | $53K | SEC ↗ |
| 2026-06-10 | APGE | Sale | 6,770 | $82.21 | $557K | SEC ↗ |
| 2026-06-10 | APGE | Sale | 7,654 | $82.78 | $634K | SEC ↗ |
| 2026-05-13 | APGE | Sale | 18.7K | $82.05 | $1.5M | SEC ↗ |
| 2026-05-13 | APGE | Sale | 1,341 | $82.58 | $111K | SEC ↗ |
| 2026-05-08 | SYRE | Sale | 24.8K | $74.76 | $1.9M | SEC ↗ |
| 2026-05-08 | SYRE | Sale | 33.5K | $73.72 | $2.5M | SEC ↗ |
| 2026-05-08 | SYRE | Sale | 19.3K | $75.35 | $1.5M | SEC ↗ |
| 2026-05-08 | SYRE | Sale | 2,404 | $72.57 | $174K | SEC ↗ |
| 2026-04-08 | APGE | Sale | 17.8K | $82.48 | $1.5M | SEC ↗ |
| 2026-04-08 | APGE | Sale | 200 | $85.00 | $17K | SEC ↗ |
| 2026-04-08 | APGE | Sale | 2,000 | $83.26 | $167K | SEC ↗ |
| 2026-03-11 | APGE | Sale | 8,363 | $74.29 | $621K | SEC ↗ |
| 2026-03-11 | APGE | Sale | 8,219 | $74.83 | $615K | SEC ↗ |
| 2026-03-11 | APGE | Sale | 3,418 | $75.86 | $259K | SEC ↗ |